openPR Logo
Press release

Photopheresis Products Market : Emerging Trends & New Medical Devices Research

01-30-2017 11:45 PM CET | Health & Medicine

Press release from: Transparency Market Research - Medical Devices

Photopheresis Products Market : Emerging Trends & New Medical

Global Photopheresis Products Market: Snapshot

Photopheresis has emerged as one of the most effective treatment options for a number of autoimmune diseases, chronic graft versus host disease, solid organ transplant rejections, and advanced cutaneous T-cell lymphoma in the past few years. The therapy, which was approved by FDA in 1988, is being largely considered as the first line of treatment for a number of diseases owing to benefits such as low rate of side effects, better safety, and efficacy as compared to other drug treatments. With the growing demand for blood derived products, the photopheresis product market is expected to gain significant traction during the forecast period.

Transparency Market Research estimates that the global photopheresis products market will exhibit a 5.9% CAGR over the period between 2016 and 2024. At this pace, the market, which had a valuation of US$223.1 mn in 2015, is expected to rise to US$ 371.1 mn by 2024.

However, it is most commonly used in treating graft versus host disease conditions. Furthermore, in 2016, Swedish government has given reimbursement for lung transplantations by using photopheresis therapy. Currently few clinical trials are undergoing on photopheresis therapy to explore its benefits to treat autoimmune disease conditions. Treatment of autoimmune diseases using photopheresis therapy is still in nascent phase. Mallinckrodt pharmaceuticals is actively conducting clinical trials on novel therapeutic indications like Cohn’s disease, multiple sclerosis conditions and more over. In 2015, Therakos Inc., was acquired by Mallinckrodt to strengthen its revenue generation from hospital segment. Based on the product type, photopheresis products are segmented into open systems and closed systems. Closed systems are mostly used globally to treat various disease conditions and these are technologically advanced systems than the open systems. In USA, closed systems dominates the market and they are approved by U.S FDA to treat cutaneous T-cell lymphoma conditions. In Europe, both closed systems and open systems are commonly preferred to treat various disease conditions.

Browse Global Strategic Business Report:
http://www.transparencymarketresearch.com/photopheresis-products-market.html

North America to Continue to Gain Massive Portion of the Pie

Transparency Market Research (TMR) states that the market will exhibit a 5.9% CAGR from 2016 through 2024. As a result, the market will rise to US$371.1 mn by 2024 from US$223.1 mn in 2015. In terms of product type, the segment of closed system photopheresis products accounted for over 80% of the overall market in 2015 and is expected to remain the dominant segment over the forecast period as well. North America, with over 52% of the global photopheresis products market in 2015, will continue to command a prominent position in the global market over the forecast period as well.

Government Reimbursements to Act as Strong Driving Force

Safer and effective treatment by using photopheresis technique is expected to be one of the potential drivers of the photopheresis products market during the forecast period. Most of the methods currently used for treating conditions such as graft-versus-host and cutaneous T-cell lymphoma lead to certain side effects. The promise of better safety and efficacy of the extracorporeal photopheresis (ECP) therapy has led to the rising preference of healthcare practitioners to this technique over other drug treatments.

Government bodies are also increasingly encouraging patients to undergo ECP therapy to treat a variety of diseases in the form of reimbursements for the therapy. The favorable reimbursement policies and the resultant coverage of medical expenses under government-supported refunds is encouraging patients to undergo ECP therapy to treat various disease conditions.

Furthermore, there has been a significant rise in the global population with cutaneous T-cell lymphoma (CTL), a rare type of non-Hodgkin lymphoma that affects the skin. According to the Cutaneous Lymphoma Foundation, the rate of incidence of CTL is nearly 1500 new cases per year in the U.S. and prevalence of continues to rise in the country as well as across the globe. Although several types of therapies are used to treat CTL, ECP is being increasingly considered the first line of therapy for treating CTL.

High Costs and Lengthy Treatments to Limit Adoption

Despite being reimbursed by the government in several regions across the globe, the cost of ECP therapy is significantly high. Moreover, the therapy takes longer time to perform and treat than many other popular treatments. It is estimated that on an average, the ECP therapy requires nearly two to three hours at a stretch for the treatment to complete for various disease. Also, the patient is required to undergo the treatment once every two weeks for a year. The cost of per treatment is around US$8000 per treatment.

On a whole, the time and money invested to complete the treatment is immense. This factor may make the treatment less attractive for many patients and may compel healthcare practitioners to switch to other low-cost and less time consuming treatments, restraining the overall growth prospects of the global photopheresis products market. The lack of enough ECP therapy centers across many developed and developing countries is also a key challenge for the market.

This review of the market is based on a recent market research report published by Transparency Market Research, titled “Photopheresis Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”

Download Exclusive Brochure of This Report :
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14771

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Photopheresis Products Market : Emerging Trends & New Medical Devices Research here

News-ID: 424558 • Views: 398

More Releases from Transparency Market Research - Medical Devices

Dermatoscope Market - Global Industry Analysis 2024
Dermatoscopy is a process through which the examination of skin lesions can be determined using an instrument, i.e., dermatoscope. The instrument is used by dermatologists to distinguish benign tumors and malignant (cancerous) lesions, especially in the diagnosis of melanoma. Modern dermatoscope uses the liquid medium and polarized light in order to cancel out the skin surface reflection. The images or videos are digitally processed using a digital epiluminescence dermatoscope. 3Gen
Medical Dynamometer Market - Global Industry Analysis and Forecast 2016 - 2024
Dynamometer is a device used for measuring the torque and brake power which is required to operate a driven machine. Dynamometer is designed to be driven in the form of an absorption or passive dynamometer. The device can be in the form of pinch gauge, which is a handheld medical device used for measuring patients’ hand strength and trauma and for determining ongoing therapy and treatment process. It is utilized
Radiation Monitoring and Dosimeter Badges Market - Global Industry Analysis 2016 …
Radiation monitoring is a process that measures the radiation dose or number of radioactive particles reaching a particular surface or area. The radiation monitor device calculates the quantity of radiation present in a given space or received by an individual. The monitors are sensitive and possess properties such as speed counting, spatial resolution, and energy resolution. Radiation monitoring instruments or radiation monitors are used for both individual monitoring and area
Clinical Trial Imaging Market - Analysis and future growth opportunities by 2024
Medical imaging plays a prominent role in clinical trials as it can help in providing answers to the critical challenges that occur in drug development process. It takes about 15 years for a drug to move from a laboratory set-up to FDA approval. The chances of a compound getting regulatory approval are minimal as out of 6 to 11,000 compounds that are evaluated in the pre-clinical stage, only 5 are

All 5 Releases


More Releases for ECP

In line with the 17 Sustainable Development Goals: digital 5th ECP with over 1,2 …
• More than 350 participants from 30 countries met for the digital 5th ECP (European Chemistry Partnering) • In more than 1,200 online partnering conversations as well as numerous flash sessions, the traditional spirit of the largest speed dating event of the European chemical industry came alive again. March 01, 2021, Frankfurt / Main, Germany Corona notwithstanding: The 5th ECP lives – and is probably even more important than ever. The digital three-day
11 Chemistry Start-ups from the Netherlands will attend the ECP Summer Summit
- Brightlands Innovation Factory is an ECP Partner and Gold Sponsor - Event location: Henkel KGaA in Düsseldorf - Partnering has started: Several hundred Speed Dating appointments anticipated 11 September 2018, Frankfurt am Main The first ECP Summer Summit / European Chemistry Partnering will take place on September 25, 2018 in Düsseldorf at the headquarters of the consumer and industrial goods company Henkel. The Brightlands Innovation Factory from the Netherlands will introduce eleven Start-up
Minister Andreas Pinkwart is the Patron of the ECP Summer Summit
Prof. Dr. Andreas Pinkwart, Minister for Economic Affairs, Innovation, Digitization and Energy of the State of North Rhine-Westphalia, has assumed patronage of the first ECP Summer Summit. The summer version of the European Chemistry Partnering will take place on September 25, 2018 at the consumer and industrial goods company Henkel in its capacity as the main sponsor of the event. “The chemical industry is a pillar of prosperity and employment. This
Assisted Living Software Market By Key Vendors: AL Advantage, ALIS, iCareManager …
Qyresearchreports include new market research report Assisted Living Software to its huge collection of research reports. Several regional and global trends account for the attractive stride the global Assisted Living Software market is experiencing over the forecast period. The report offers a granular assessment of all such trends impacting the current outlook and emerging growth dynamics. The study on the global Assisted Living Software market highlights the key factors shaping the
MyBinding.com Partners with Akiles to Offer the CoilMac ECP Series Coil Binding …
HILLSBORO, OR, April 15, 2012 – MyBinding.com, one of the country's leading Internet retailers of binding machines and supplies, recently added the Akiles CoilMac ECP series binding equipment to their website. MyBinding.com has a long history of working with Akiles. Currently they offer a huge selection of Akiles binding machines, laminators, corner rounders, supplies, and more. The decision to add the CoilMac ECP series to their extensive Akiles inventory was
Pixelmetrix Electronic Couch Potato™ (ECP™) - Now Shipping
IBC 2008, Amsterdam, September 12, 2008 – Pixelmetrix, the global expert in Preventive Monitoring for digital television and IPTV networks, is now shipping its Electronic Couch Potato™ (ECP™). Demonstrations are available at Pixelmetrix Booth 1C39. The Pixelmetrix Electronic Couch Potato™ (ECP™) is an after the network probe that measures and reports the end-users’ experience for delivered video services. Collecting telemetry from multiple ECPs™ distributed across a wide network and